Article
Molecular biomarkers for lung adenocarcinoma.
The European respiratory journal - 1 Apr 2017
Calvayrac Olivier, Pradines Anne, Pons Elvire, Mazières Julien, Guibert Nicolas
Abstract excerpt
The identification of oncogenic driver alterations that underlie sensitivity to small inhibitors has led to growing interest in identifying additional targetable oncogenes in nonsmall cell lung cancer. Although the therapeutic impact of the discovery of these alterations has now been widely demonstrated, the epidemiological data associated with each of these biomarkers remain insufficiently studied. In this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
